Renaissance Capital logo

CBUS News

Gene-edited seed developer Cibus officially withdraws $100 million IPO

CBUS

Cibus, which is developing gene-edited crop traits for the global seed industry, officially withdrew its plans for an initial public offering on Friday. It had filed to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. The San Diego, CA-based company was founded in 2001 and booked $3 million in sales for the 12 months ended September 30, 2018....read more

US IPO Weekly Recap: Blue jeans are back as Levi's preps March IPO

VTUS

Levi Strauss (LEVI) is bringing its blue jeans back to public markets. This week the company filed for an IPO that we estimate could raise $750 million, coming as early as March. It's no wonder Levi is going public, based on its 2017 and 2018 financials, which saw sales growth of 8% and 14%, respectively. That's especially impressive given the current...read more

Bad seed: gene-edited crop traits developer Cibus postpones $100 million IPO

CBUS

Cibus, which is developing gene-edited crop traits for the global seed industry, postponed its IPO on Thursday. It had filed to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. The San Diego, CA-based company was founded in 2001 and booked $3 million in sales for the 12 months ended September 30, 2018. It had planned to list on the Nasdaq under...read more

US IPO Week Ahead: On track for 7 IPOs, led by Virgin Trains USA

VTUS

Railroad IPOs were hot in the 1850's, but two billionaires are bringing the industry back this week with an offering of Virgin Trains USA. In total, the week could see up to seven deals, but Virgin Trains USA's $510 million IPO is larger than the other six combined. These others are mostly small healthcare IPOs: ...read more